HCV Genotype Distribution and Clinical Characteristics of HCV Mono-Infected and HCV/HIV Co-Infected Patients in Liangshan Prefecture, Sichuan Province, China

被引:1
|
作者
Cao, Bianchuan [1 ]
Liu, Mei [2 ]
Jiang, Tao [2 ]
Yu, Qinghua [2 ]
Yuan, Tianru [2 ]
Ding, Ping [2 ]
Zhou, Xian [2 ]
Huang, Yongmao [1 ]
Zou, Yongsheng [1 ]
Huang, Fuli [1 ,3 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
[2] First Peoples Hosp Yuexi Cty, Antiviral Therapy Ctr, Liangshan, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Dept Infect Dis, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
关键词
hepatitis c; HIV; genotype distribution; clinical characteristics; INJECTION-DRUG USERS; VIRUS-INFECTION; DIAGNOSIS;
D O I
10.1177/23259582231217810
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The present study aimed to characterize the genotype distribution and clinical characteristics of HCV monoinfected and HCV/HIV coinfected patients in the Liangshan Prefecture, Sichuan Province, China. Methods: All the patients were divided into HCV monoinfection and HCV/HIV coinfection groups according to whether they were complicated with HIV infection. The data from the two groups were collected. Results: In this study, HCV genotype 3 was the most common genotype in both groups, while HCV genotype 6 was significantly higher in the coinfection group than in the monoinfection group (p = 0.046). The white blood cell count, total bilirubin level, and HCV RNA were significantly higher in the HCV monoinfection group than that in the HCV/HIV coinfection group (p = 0.031; p < 0.001; p = 0.027, respectively). Conclusion: HCV prevalence was high in HIV-positive patients in the Liangshan Prefecture. Thus, incorporating screening and management of HCV monoinfection and HCV/HIV coinfection is needed in local region programs.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
    Maughan, A.
    Sadigh, K.
    Angulo-Diaz, V.
    Mandimika, C.
    Villanueva, M.
    Lim, J. K.
    Ogbuagu, O.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [42] Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients
    Salmon-Ceron, Dominique
    Nahon, Pierre
    Layese, Richard
    Bourcier, Valerie
    Sogni, Philippe
    Bani-Sadr, Firouze
    Audureau, Etienne
    Merchadou, Laurence
    Dabis, Francois
    Wittkop, Linda
    Roudot-Thoraval, Francoise
    Nahon, P.
    Layese, R.
    Roudot-Thoraval, F.
    Bedossa, P.
    Bonjour, M.
    Bourcier, V.
    Dharancy, S.
    Durand-Zaleski, I.
    Fontaine, H.
    Guyader, D.
    Laurent, A.
    Leroy, V.
    Marche, P.
    Salmon, D.
    Thibault, V.
    Vilgrain, V.
    Zucman-Rossi, J.
    Cagnot, C.
    Petrov-Sanchez, V.
    Nahon, P.
    Bourcier, V.
    Pol, S.
    Fontaine, H.
    Benhamou, Y.
    Serfaty, L.
    Roulot, D.
    Marcellin, P.
    Mallat, A.
    Attali, P.
    Grange, J. D.
    Capron, D.
    Cales, P.
    Bourliere, M.
    Bronowicki, J. P.
    Tran, A.
    Mal, F.
    Christidis, C.
    Silvain, C.
    Guyader, D.
    HEPATOLOGY, 2019, 70 (03) : 939 - 954
  • [43] Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
    A. Maughan
    K. Sadigh
    V. Angulo-Diaz
    C. Mandimika
    M. Villanueva
    J. K. Lim
    O. Ogbuagu
    BMC Infectious Diseases, 19
  • [44] Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects
    Bono, Valeria
    Tincati, Camilla
    Van den Bogaart, Lorena
    Cannizzo, Elvira Stefania
    Rovito, Roberta
    Augello, Matteo
    De Bona, Anna
    Monforte, Antonella D'Arminio
    Milazzo, Laura
    Marchetti, Giulia
    VIRUSES-BASEL, 2022, 14 (08):
  • [45] Intrauterine Blood Transfusion in an HCV and HIV Co-Infected Woman
    Charison Jodie C.
    Schneider Carol E.
    Poliquin Vanessa
    母胎医学杂志(英文), 2021, 03 (01) : 69 - 70
  • [46] Impact of Observer Experience on the Reproducibility of Transient Elastometry in HIV/HCV Co-infected Patients
    Neukam, Karin
    Macias, Juan
    Ferrete, Concepcion
    Palomares, Jose C.
    Fernandez, Ana
    Mira, Jose A.
    Pineda, Juan A.
    HIV CLINICAL TRIALS, 2009, 10 (04): : 276 - 281
  • [47] Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
    Smit, Colette
    Smit, Colette
    Arends, Joop
    Peters, Lars
    d'Arminio, Antonella
    Dabis, Montforte Francois
    Zangerle, Robert
    Daikos, George
    Mussini, Christina
    Mallolas, Josep
    de Wit, Stephane
    Zinkernagel, Annelies
    Cosin, Jaime
    Chene, Genevieve
    Raben, Dorthe
    Rockstroh, Juergen
    BMC INFECTIOUS DISEASES, 2015, 15
  • [48] HCV in Peripheral Blood Mononuclear Cells Are Predominantly Carried on the Surface of Cells in HIV/HCV Co-Infected Individuals
    Natarajan, Ven
    Kottilil, Shyam
    Hazen, Allison
    Adelsberger, Joseph
    Murphy, Alison A.
    Polis, Michael A.
    Kovacs, Joseph A.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (12) : 2032 - 2037
  • [49] Update on Current Evidence for Hepatitis C Therapeutic Options in HCV Mono-infected Patients
    Hull, Mark W.
    Yoshida, Eric M.
    Montaner, Julio S. G.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (07)
  • [50] HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)
    Melina Erica Santos
    Camelia Protopopescu
    Philippe Sogni
    Issifou Yaya
    Lionel Piroth
    François Bailly
    Fabienne Marcellin
    Laure Esterle
    Linda Wittkop
    Eric Rosenthal
    Philippe Morlat
    Perrine Roux
    Wildo Navegantes de Araujo
    Dominique Salmon-Ceron
    Maria Patrizia Carrieri
    AIDS and Behavior, 2020, 24 : 1069 - 1084